French Article on Augmentation on Dopamine agonists

[Joolsg]

A helpful article by Dr Jean Marc Bugnicourt on dopamine agonists.

He confirms that DAs should no longer be first line medications and that gabapentinoids often do not work on patients who have augmented on DAs.

He points out that there are limited medications available to treat RLS, but does mention dipyradimole, perampanel and Ganoderma Lucidum mushrooms.

He also mentions Tramadol, but not the other low dose opioids set out in the Mayo Algorithm.

Hopefully, the realisation of the dangers of DAs will spread throughout Europe and these drugs will soon stop being prescribed.

e-jsm.org/journal/view.php?...

[amrob123]

Thanks for sharing this Jools.

Hopefully the greater the number of published papers with this consistent message, the greater the likelihood that message will be heeded by medicos!

I found the section on why taking a Dopamine Agonist is not logical from a pathophysiological point of view particularly interesting.

It will also be interesting to see whether the early Ganoderma Lucidum results bear out in subsequent trials.

[Tildabri]

Thanks very much Jools. This may come in very handy in persuading my French doctor to take some sort of serious interest in my condition 👍

[Joolsg in reply to Tildabri]

Sadly, most doctors worldwide still know nothing about RLS and seem reluctant to learn 😢.